A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)

Simple item page
dc.contributor.authorYurdaydın, Cihan
dc.contributor.authorWedemeyer, Heiner
dc.contributor.authorDalekos, George
dc.contributor.authorErhardt, Alexander
dc.contributor.authorÇakaloğlu, Y.
dc.contributor.authorDeğertekin, H.
dc.contributor.authorZeuzem, Stefan
dc.contributor.authorZachou, Kalliopi
dc.contributor.authorBozkaya, Hakan
dc.contributor.buuauthorGürel, S.
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Gastroenteroloji Bilim Dalı.tr_TR
dc.date.accessioned2022-11-01T06:26:26Z
dc.date.available2022-11-01T06:26:26Z
dc.date.issued2006-10
dc.descriptionBu çalışma, 27-31 Ekim 2006 tarihleri arasında Boston[Amerika Birleşik Devletleri]’da düzenlenen 57. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.tr_TR
dc.description.sponsorshipAmer Assoc Study Liver Disen_US
dc.identifier.citationYurdaydın, C. vd. (2006). ''A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)''. Hepatology, 44(4), Suplement 1, 230A-230A.en_US
dc.identifier.endpage230Atr_TR
dc.identifier.issn0270-9139
dc.identifier.issue4, Supplement 1en_US
dc.identifier.startpage230Atr_TR
dc.identifier.urihttp://hdl.handle.net/11452/29286
dc.identifier.volume44tr_TR
dc.identifier.wos000241362300112
dc.indexed.wosSCIEen_US
dc.indexed.wosCPCISen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationYurt dışıtr_TR
dc.relation.journalHepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararasıtr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGastroenterology & hepatologyen_US
dc.subject.wosGastroenterology & hepatologyen_US
dc.titleA multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)en_US
dc.typeMeeting Abstract
dc.wos.quartileQ1en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science